We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
William M. Feinberg Lecture: Asymptomatic Carotid Stenosis: Current and Future Considerations
Summary
This review of asymptomatic carotid stenosis management identifies microplastics and nanoplastics as an emerging risk factor for cardiovascular disease, alongside traditional atherosclerotic factors. The author notes that strategies to limit microplastic exposure will be important for stroke prevention, as no specific medical therapies currently exist to counteract microplastic-related vascular damage.
Asymptomatic high-grade carotid stenosis is an important therapeutic target for stroke prevention. For decades, the ACAS (Asymptomatic Carotid Atherosclerosis Study) and ACST (Asymptomatic Carotid Surgery Trial) trials provided most of the evidence supporting endarterectomy for patients with asymptomatic high-grade stenosis who were otherwise good candidates for surgery. Since then, transfemoral/transradial carotid stenting and transcarotid artery revascularization have emerged as alternatives to endarterectomy for revascularization. Advances in treatments against atherosclerosis have driven down the rates of stroke in patients managed without revascularization. SPACE-2 (Stent-Protected Angioplasty Versus Carotid Endarterectomy-2), a trial that included endarterectomy, stenting, and medical arms, failed to detect significant differences in stroke rates among treatment groups, but the study was stopped well short of its recruitment goal. CREST-2 (Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial) will be able to clarify whether revascularization by stenting or endarterectomy remains efficacious under conditions of intensive medical management. Transcarotid artery revascularization has a favorable periprocedural risk profile, but randomized trials comparing it to intensive medical management are lacking. Features like intraplaque hemorrhage on MRI and echolucency on B-mode ultrasonography can identify patients at higher risk of stroke with asymptomatic stenosis. High-grade stenosis with poor collaterals can cause hemispheric hypoperfusion, and unstable plaque can cause microemboli, both of which may be treatable risk factors for cognitive impairment. Evidence that there are patients with carotid stenosis who benefit cognitively from revascularization is presently lacking. New risk factors are emerging, like exposure to microplastics and nanoplastics. Strategies to limit exposure will be important without specific medical therapies.
Sign in to start a discussion.
More Papers Like This
Abstract Tu0030: Carotid Plaque Microplastics are Associated with Clinical Symptoms and Mesenchymal Stem Cell-Macrophage Immunomodulatory Effects
This conference abstract reports findings from a study linking micronanoplastic content in carotid artery plaques with clinical symptoms and with altered immune signaling mediated by mesenchymal stem cells. Patients with symptomatic carotid stenosis had higher plaque microplastic loads, and stem cells modulated the inflammatory response in ways that differed based on microplastic presence.
Microplastics and Nanoplastics in Atheromas and Cardiovascular Events
This landmark clinical study found that patients with micro- and nanoplastics detected in their carotid artery plaque had a significantly higher risk of heart attack, stroke, or death over a 34-month follow-up period compared to those without detectable plastics. This is one of the first studies to directly link microplastic presence in human blood vessels to worse cardiovascular outcomes. The findings suggest that plastic accumulation in arteries may be an important and previously unrecognized risk factor for heart disease.
Evidence, Mechanisms, and Clinical Implications of Microplastics and Nanoplastics As Emerging Cardiovascular Risk Factors: A Narrative Review
This review examines growing evidence that micro- and nanoplastics may contribute to cardiovascular health risks, with researchers having found these particles in human artery plaques and blood clots. Evidence indicates that the particles can enter the bloodstream, trigger inflammation, damage blood vessel walls, and potentially increase the risk of heart attacks and strokes. While the evidence is not yet conclusive, the study highlights an emerging area of concern that warrants further investigation into how everyday plastic exposure may affect heart and blood vessel health.
Micro- and Nanoplastics as a Potential Risk Factor for Stroke: A Systematic Review
This systematic review assessed the potential link between micro- and nanoplastics and stroke risk. It found that plastic particles have been detected in human blood vessels and arterial plaques, and may contribute to inflammation and blood vessel damage — factors that could increase the risk of stroke.
P69 | Microplastics and Atherosclerosis: Evidence of Microplastics in Carotid Atherosclerotic Plaques
This conference abstract reports the detection of multiple types of microplastics in human coronary, carotid, and aortic arteries, finding higher MP concentrations in arteries with atherosclerotic plaques than in plaque-free aortic tissue, suggesting a link between microplastic accumulation and arterial disease.